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ARTICLE
Spatiotemporal segregation of human marginal
zone and memory B cell populations in lymphoid
tissue
Yuan Zhao1, Mohamed Uduman2, Jacqueline H.Y. Siu3, Thomas J. Tull1, Jeremy D. Sanderson1,
Yu-Chang Bryan Wu 4, Julian Q. Zhou 5, Nedyalko Petrov6, Richard Ellis6, Katrina Todd6,
Konstantia-Maria Chavele1, William Guesdon1, Anna Vossenkamper7, Wayel Jassem8, David P. D’Cruz1,
David J. Fear1, Susan John 1, Dagmar Scheel-Toellner 9, Claire Hopkins1, Estefania Moreno7,
Natalie L. Woodman10, Francesca Ciccarelli10, Susanne Heck6,
Steven H. Kleinstein 2,5,11, Mats Bemark 12 & Jo Spencer1
Human memory B cells and marginal zone (MZ) B cells share common features such as the
expression of CD27 and somatic mutations in their IGHV and BCL6 genes, but the relationship
between them is controversial. Here, we show phenotypic progression within lymphoid tissues
as MZ B cells emerge from the mature naïve B cell pool via a precursor CD27−CD45RBMEM55+
population distant from memory cells. By imaging mass cytometry, we ﬁnd that MZ B cells and
memory B cells occupy different microanatomical niches in organised gut lymphoid tissues.
Both populations disseminate widely between distant lymphoid tissues and blood, and both
diversify their IGHV repertoire in gut germinal centres (GC), but nevertheless remain largely
clonally separate. MZ B cells are therefore not developmentally contiguous with or analogous
to classical memory B cells despite their shared ability to transit through GC, where somatic
mutations are acquired.
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Marginal zone (MZ) B cells are CD27
+IgM+IgD+ cells
that occupy the microanatomical niche on the periph-
ery of the white pulp in the spleen of humans1–3.
They make innate-like responses to T independent antigens and
are major contributors to systemic anti-bacterial immunity3,4.
Phenotypically similar cells in blood are often referred to as cir-
culating MZ B cells5. The populations share many properties
with memory B cells that provide high afﬁnity antibody responses
to recall antigens, including expression of CD27 and
somatic mutations in Ig V regions and BCL6 that are classically
acquired during germinal centre (GC) responses6,7. Despite these
similarities, the prevailing hypothesis is that MZ B cells are
not bona ﬁdememory B cells but rather a separate lineage derived
from CD27− precursors that express the CD45RBMEM55
epitope (CD45RB+) through ligation of NOTCH2 in spleen8,9.
It has been suggested that they may acquire somatic
mutations independent of GC1,10. This scheme, whilst supported
by studies of blood and spleen from children9; emergence of
B cells following haematopoietic stem cell transplantation8; and
the presence of such cells in patients lacking CD40 signalling10,
is yet to gain general acceptance and cannot explain where MZ
B cells proliferate to acquire somatic mutations in their IGV
genes.
In healthy humans, both spleen and gut-associated lymphoid
tissue (GALT) have microanatomically deﬁned MZs11. These
sites may share a lymphocyte pool as their endothelial and reti-
cular structures express MAdCAM1 that have the potential to
recruit cells expressing α4β7 integrin12. Thus, circulating MZ-like
B cells could be in transit between spleen and GALT. In support
of shared B cell populations, self-reactive IgM-expressing MZ B
cell lymphomas of mucosa-associated lymphoid tissue can
metastasise to the splenic MZ13. Moreover, GALT is required for
the development of the splenic marginal zone in rabbits14. Whilst
a recent study proposed that the IgM-expressing CD27+ cells in
GALT are memory B cells rather than MZ B cells, it did not
consider the possibility that MZ B cells characterised by their IgD
expression may also be present, and made conclusions based on
the properties of CD27+IgM+IgD− cells (IgM-only cells) from
the gut15.
To resolve these issues, we visualise phenotypic progression in
B cells isolated from human GALT, spleen and tonsils by mass
cytometry. We observe that MZ B cells in these tissues are phe-
notypically linked to a CD27−CD45RB+ precursor population,
forming a separate developmental branch from the naïve B cell
pool that was phenotypically separate from that of memory B
cells. Imaging mass cytometry is used to localise MZ B cells in
GALT. This demonstrates that MZ B cells and memory B cells
reside in different microanatomical niches. Whereas memory B
cells occupy the lymphoid tissue boundaries, MZ B cells have a
more limited distribution adjacent to the GC. Finally, we use
IGHV gene analysis to identify that both MZ B cells and memory
B cells disseminate between distant sites of GALT and circulate in
the blood, and that both can diversify their IGHV genes in the GC
of GALT whilst remaining clonally separate. We conclude that
human MZ B cells develop separately from classical memory B
cells and that their archetypical mutations are likely introduced as
they proliferate in GALT GC.
Results
Visualisation of B cells from tissues by mass cytometry. For an
in-depth comparison of B cell variability within and between
human lymphoid tissues, we undertook deep phenotypic proﬁling
by mass cytometry of cell suspensions prepared from GALT, tonsil
and spleen and using a panel of 35 markers of B cell subset identity,
migratory capacity and function (Supplementary Table 1).
Following normalisation, quality control and gating on single CD45
+CD3−CD14−CD19+ B cells, multidimensional scaling of samples
identiﬁed that biological replicates of each tissue separately clustered
together16 (Supplementary Fig. 1, Supplementary Fig. 2). Data from
each tissue were concatenated, and viSNE plots demonstrated
expression of subset markers CD10, CD24, CD27, CD38, IgM, IgA,
IgG, IgD and HLA-DR on subpopulations of B cells (Fig. 1a,
Supplementary Fig. 3). SPADE trees were individually constructed
from the viSNE analysis of the different tissues, and 11 major B cell
subsets were identiﬁed and enclosed in SPADE bubbles (Fig. 1b, c,
Supplementary Fig. 4). These included a novel CD27−IgM+IgD−
subset that was phenotypically similar to IgA expressing memory
cells. The memory cell subsets were phenotypically distant from the
CD27+IgM+IgD+ MZ population, and CD27+IgM+IgD− (IgM-
only) cells were phenotypically more similar to CD27+IgM+IgD+
cells than cells within the memory cell compartments.
Phenotypic alignment of CD27+IgM+IgD+ cells and pre-
cursors. As expected, CD45RB was expressed by CD27+ and
CD27− cells17. Consistent with the proposed NOTCH2-
dependent developmental sequence, CD27−CD45RB+ cells in
the naïve B cell SPADE bubble were positioned adjacent to
CD27+IgM+IgD+ cells in all tissues (Fig. 1d)8,9. Importantly, this
occurred despite the fact that we did not include CD45RB
expression in the viSNE criteria (Fig. 1a, c). A bootstrapping
procedure to test whether cell subpopulations signiﬁcantly differ
from each other revealed that the CD45RB+ cells were sig-
niﬁcantly different to the CD45RB− cells within the naïve B cell
SPADE bubble18–20. Most notably CD27−IgM+IgD+CD45RB+
cells consistently expressed signiﬁcantly higher levels of CD24
and IgM and lower IgD than other CD27−IgM+IgD+CD45RB−
naïve cells across all tissues (Fig. 2a). A separate SPADE bubble
was created around the CD27−IgM+IgD+CD45RB+ cells that
was designated as an independent population in subsequent
analysis (Fig. 2b). When the sizes and spatial locations of the
12 subsets in tissues were visualised back on the viSNE maps, the
CD27−IgM+IgD+CD45RB+ cells were positioned between
CD27+IgM+IgD+ and naïve cells (Fig. 2c).
Having observed phenotypic alignment of CD27+IgM+IgD+
and their CD27−CD45RB+ precursor population according to B
cell subset parameters, we undertook a separate hierarchical
clustering of the 12 B cell subsets from all three tissues based on
all 34 parameters measured21. We observed that in each tissue
CD27+IgM+IgD+ cells were signiﬁcantly aligned to their CD27−
CD45RB+ precursor population, and that this cluster was
positioned closer to naïve and transitional cells than to class
switched memory cells (Fig. 2d).
A B cell subset may be different in different tissues. The relative
proportions of subsets in tissues were consistent with current
concepts of tissue structure and composition, including larger GC
compartments in GALT and tonsil than spleen and a larger
CD27+IgM+IgD+ MZ population in spleen than either other
tissue (Fig. 3a, b). The relatively large proportion of CD27+IgM
+IgD− observed in GALT compared to spleen and tonsils in
SPADE plots was also evident here (Fig. 3b). Further analysis of
median expression of markers of interest within B cell subsets
revealed that B cells from each tissue expressed different proﬁles
of molecules that mediate and direct cell trafﬁc, indicating that
these may have facilitated entry or have been imprinted following
entry (Fig. 3c). In addition, splenic B cell subsets generally had
relatively high expression of CD21 and CD180 compared to
equivalent subsets in tonsil, and CD27+IgM+IgD+ B cells from
GALT and tonsil as well as CD27−CD45RB+ cells from tonsil
expressed higher levels of CD69 and FcRL4 compared to subset
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counterparts isolated from spleen. In GALT, CD27+IgM+IgD+ B
cells and and CD27−CD45RB+ also had relatively high expres-
sion of CD80 compared to the same subset in other tissues
(Fig. 3d).
GALT MZ and class switched cells have different locations. The
markedly different expression of the normally epithelial-
associated molecules CD80 and FcRL4 by CD27+IgM+IgD+
compared to CD27+IgM− B cells in GALT suggests that these
populations may occupy different microanatomical niches22–25.
To test this, we used imaging mass cytometry to determine the
distribution of B cell subsets in GALT in three samples of human
appendix and tonsil26,27. Glass mounted tissue sections were
stained with lanthanide conjugated CD19, CD20, CD10, CD27,
CD24, CD38, CD45RB, IgM, IgD, CD86, CD3, CD45 and cyto-
keratin (Supplementary Table 2). A high-powered UV laser then
ablated the tissue spot by spot with a resolution of 1000 nm. The
resulting cloud of particles was transported into the argon plasma
of a Helios instrument (Fluidigm) where they were atomised and
ionised. The metal-isotope ion content, and, by inference, epitope
abundances and distributions, were determined in a time-of-ﬂight
mass analyser. Each laser shot by this method is akin to a pixel of
a tissue image which can be recomposed to a complete image.
This ground-breaking technology allows high multiplexing of
antigen staining in histology samples and subsequent high
dimensional data analsyis.
GALT zonal structure was visualised by cytokeratin (epithe-
lium), CD3 (T cells), CD20 (B cells) and CD86 (dendritic cells) by
imaging mass cytometry (Fig. 4a). The visualisation of B cell
subsets by colour mixing generated complex patterns that were
difﬁcult to interpret even when only a selection of the required
markers was used (Fig. 4b). We therefore designed an alternative
strategy to identify the distribution of B cell subsets as single
colour pixels on an image as summarised in Supplementary
Fig. 5. We validated our subset classiﬁcations by comparing the
expression of CD45RB and CD24 that were not used for B cell
subset designation in image mass cytometry between mass
cytometry and imaging mass cytometry, and found that these
agreed (Supplementary Fig. 6).
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Fig. 1 Deep immunophenotypic proﬁling of B cells in human tissues. a viSNE projections of the B cell compartment in tissues (GALT n= 8; tonsil n= 5,
spleen n= 6). Data were clustered according to criteria used to deﬁne known B cell subsets: CD27, CD24, CD28, CD10, IgM, IgD, IgA, IgG and HLA-DR.
b Key to B cells subsets identiﬁed in the SPADE plots in c that were created for each tissue to enable comparisons of their compositions. Expression of
CD27, IgM and IgD are illustrated. d Visualisation of the expression of CD45RB in B cell subsets when CD45RB was not one of the clustering criteria.
Arrows identify the location of CD45RB+ cells in the naïve B cell SPADE bubble
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Fig. 2 CD27−IgM+IgD+CD45RB+ marginal zone precursor B cells emerge from the naïve B cell pool. Analysis of B cells in GALT (n= 8); tonsil (n= 5),
spleen (n= 6). a Z-score outcomes of a permutation test to determine if cell subpopulations signiﬁcantly neighbour each other more than by random
chance. This revealed that the CD45RB+ cells were signiﬁcantly different to the CD45RB- cells within the naïve B cell SPADE bubble by their over
expression of CD24, IgM, CD45 in addition to CD45RB and lower expression of BCMA, HLA-DR, IgD and CD38. b A SPADE bubble was therefore placed
around the CD27−CD45RB+ cells to be considered as a separate subset for inclusion in subsequent analysis, as illustrated for spleen. c All subsets (GC
germinal centre, PB plasmablasts, TS transitional cells) were then visualised back on the viSNE plots for comparison where CD27−IgM+IgD+CD45RB+
cells were intermediate between naïve and CD27+IgM+IgD+ marginal zone subsets. d A separate hierarchical clustering method that considered all
markers used for mass cytometry aligned CD27−IgM+IgD+CD45RB+ cells with CD27+IgM+IgD+ marginal zone cells and placed both closer to the naïve
and transitional B cell subsets than conventional memory compartments
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The positions of pixels indicating CD27+IgM+IgD+ MZ
B cells, CD27+IgM− class switched memory cells (CSM),
CD27−IgM+IgD+ naïve B cells and CD10+IgD− GC cells are
illustrated in Fig. 4c–g. The pixels representing CD27+IgM− cells
were located on the periphery of the lymphoid tissue (Fig. 4c, d,
g), surrounding the CD27+IgM+IgD+ MZ population, demon-
strating for the ﬁrst time that these populations occupy different
microanatomic niches (Fig. 4c–e). CD27+IgM− cells also
extended around the serosal aspect of the GC and around the T
cell zone (Fig. 4c). CD27+IgM+IgD+ and some CD27−IgM+IgD
+ naïve B cells occupied a space closest to the GC and the CD27
−IgM+IgD+ naïve B cells also extended around the T cell zone.
Sparsity of naïve B cells in the zone between the GC and the
follicle-associated epithelium was observed in 2 of the 3 specimens
of appendix analysed Supplementary Fig. 7, suggesting that some
cells often considered to be naïve by observation of IgM and IgD
co-expression in tissues can be misidentiﬁed without considera-
tion of CD27.
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High expression of FcRL4 and CD80 has previously been
associated with activation and epithelial localisation, and their
relatively high expression on CD27+IgM+IgD+ cells (Fig. 3d)
suggested that these may be more closely associated with epithelia
than CD27+IgM− cells. However, this was not evident in tissue
sections, where it was rather CD27+IgM− cells that tended
to occupy the sub-epithelial space (Fig. 4d). Visualisation
CD27+IgM+IgD+ and CD27+IgM− cells together with FcRL4
revealed that the FcRL4+ population included representatives of
both subsets (Fig. 4h–l). CD80 and CD86 have been observed on
B cells in the follicle-associated epithelium and sub-epithelial
dome region of GALT previously25. Unfortunately, CD80 gave no
signal in tissues and CD86 was not identiﬁed on B cells other
than in the GC by imaging mass cytometry (Supplementary
Fig. 8). The distributions of CD27+IgM+IgD+ cells and their
CD27−CD45RB+ precursors were similar in tissue (Supplemen-
tary Fig. 9). The CD27+IgM+IgD− (IgM only) population was
distributed amongst both CD27+IgM+IgD+ and CD27+IgM−
populations (Supplementary Fig. 10). Intraepithelial B cells in
follicle-associated epithelium had diverse phenotypes, demon-
strating that this niche is not occupied by a single B cell subset
(Supplementary Fig. 11)
Human CD27+IgM+IgD+ B cells are widely disseminated. As
discussed above, mass cytometry showed that CD27+IgM+IgD+
MZ cells are phenotypically similar to their CD27−CD45RB+
precursors but distant to memory cell subsets. In addition, ima-
ging mass cytometry demonstrated that CD27+IgM+IgD+ cells
have a different microanatomical distribution to CD27+IgM−
class switched memory cells. To further investigate the spatial
distribution of CD27+IgM+IgD+ vis-á-vis memory B cell clones
and how they relate to ongoing responses in GALT GC within
and between GALT sites we used IGHV gene sequencing of
sorted cells.
Three distant GALT sites and peripheral blood were sampled
from four separate healthy individuals. The GALT sites spanned a
metre of intestine, and included Peyer’s patches in the terminal
ileum (PP), the lymphoid tissue around the periappendiceal
oriﬁce (A) and the boundary of the colon and rectum (CF)
(Supplementary Fig. 12). Although separate precise sampling of
these sites limited the cell numbers from each site available for
analysis, it allowed observation of clone dissemination and clone
sharing that could only occur via cellular recirculation through
lymph and blood.
An initial ﬂow cytometric analysis showed that GALT B cells
from PP, A and CF had very similar phenotypes to each other and
each was consistent with analysis of GALT by mass cytometry
(Supplementary Fig. 13). Following the scheme in Supplementary
Fig. 14 we used PCR with MID tagged second round primers to
the constant region, to amplify Ig isotypes separately28. We
analysed GC, CD27+IgD+ and CD27+IgD− cells from each site
of GALT and CD27−IgD+ naïve B cells, CD27+IgD+ and
CD27+IgD− cells and plasmablasts from blood. After quality
control and initial bioinformatics analysis of IgH gene sequences
the data comprised in total 80,710 unique sequences that were
clustered into 50,862 different clonal families. Identical sequences
were very rarely (0.006%) shared across multiple donors,
consistent with the frequency of previously observed rare ‘public’
clones29 (Supplementary Fig. 15). With the exception of blood
CD27− naïve B cells, all subsets expressed mutated IgHV gene
rearrangements with no obvious differences within a subset
irrespective of tissue site5,30 (Supplementary Fig. 16). B cells from
the CD27+IgM+IgD+ subset, whilst harbouring mutated IgHV,
had a lower frequency of mutation than any of the CD27+IgD−
subsets, the GC cells or blood plasmablasts and IgM-only cells
had slightly lower mutation frequencies than class switched cells,
consistent with studies of these cells from blood (Supplementary
Fig. 16). No obvious differences in IgHV family usage biases were
observed (Supplementary Fig. 17).
Identical sequences and clonally related sequences were
observed between spatially separated sites within each donor
(Supplementary Fig. 15). Disseminated B cell clones were more
likely to be related to distant cells of the same isotype than to
those of other isotypes present in the same microenvironment
(Fig. 5a). Evidence of somatic diversiﬁcation within an isotype
was apparent from clonal lineage trees reconstructed based on
shared somatic hypermutation patterns (Fig. 5b). This demon-
strates migration of GALT CD27+ B cells expressing all isotypes
studied through the gut and their somatic diversiﬁcation after
undergoing class switch recombination.
In addition, clonal relationships between B cells from different
subsets were apparent in all donors. GALT CD27+IgM+IgD+ and
CD27+IgM+IgD− B cells were both associated with clones that
spanned GALT and blood. These subsets were also clonally related
to each other within GALT (Fig. 6). Importantly, CD27+IgM+IgD+
and CD27+IgM+IgD− clones both contained members that could
be found within the GC, and lineage tree analysis identiﬁed ongoing
diversiﬁcation. CD27+IgM+IgD+ B cell clone members occurred
before and after the GC stage in developmental terms and clone
members were also identiﬁable in blood (Fig. 7). It has previously
been suggested that CD27+IgM+IgD+ B cells can undergo somatic
hypermutation outside GC. However, whereas AID expression by
sorted GC cells was readily detected by quantitative PCR, neither
CD27+IgM+IgD+ nor CD27+IgM+IgD− GALT B cells expressed
AID (Supplementary Fig. 18). Thus, these results support trafﬁcking
of GALT CD27+IgM+IgD+ and CD27+IgM+IgD− B cells through
blood and GALT including the GC microenvironment where they
diversify their IGHV genes demonstrating a source of the enigmatic
IgHV mutations that are characteristic for this population.
Fig. 4 Marginal zone and class switched memory B cells occupy different microanatomical niches. a Visualisation of microanatomy of human appendix by
imaging mass cytometry. A representative example of appendix from three different donors studied. CD3 (T cells; green), CD20 (B cells; magenta), CD86
(dendritic cells; cyan) and keratin (epithelium; red). Scale bar represents 100 μm. b Conventional mixing of ﬂuorochromes did not enable the identiﬁcation of B
cell subsets that require multiple markers. The combination of CD27 (green), CD45RB (blue), CD20 (magenta) and IgD (cyan) would require the further
addition of IgM for the detection of marginal zone B cells and their putative precursors. c Pixels with signal representing CD19+CD20+CD27+IgM+IgD+ of MZ
B cells are green (approximate population boundary marked with a green dotted line). Pixels with signal representing CD19+CD20+CD27+IgM−IgD− class
switched memory (CSM) cells are magenta (approximate population boundary marked with a magenta dotted line). Importantly, pixels representing MZ and
class switched memory have different distributions. Pixels with signal representing CD19+CD20+CD10+IgD− of germinal centre (GC) cells are cyan (circled by
a cyan dotted line). In addition, pixels representing CD19+CD20+CD27−IgM+IgD+ naïve B cells are yellow and pixels representing naïve cells are also
illustrated as inserts. The epithelium is red. d An enlargement of the area of c. identiﬁed by the white rectangle. Pixel detail of the zones encircled by coloured
dotted lines is illustrated in e–g. h Expression of FcRL4 in human appendix in red. Pixels with signal representing CD19+CD20+CD27+IgM+IgD+ of MZ B cells
are blue. Expression of FcRL4 by MZ B cells is visualised as magenta pixels in i and j. Pixels with signal representing CD19+CD20+CD27+IgM−IgD− class
switched memory cells are green and so expression of FcRL4 by class switched memory cells is visualised as yellow pixels on FcRL4+ cells in k and l. FcRL4+
cells can therefore be either MZ or class switched memory cells
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Fig. 5 Dissemination of B cell clones through human gut. Analysis of B cells from three anatomical sites from each of four tissue donors. a Hierarchical
clustering of isotype-speciﬁc B cell clones at different sites in the gut and blood. Each row represents a single clone, and columns represent site-isotype
combinations. The grayscale represents the log10 transformed number of unique sequences in each clone. The hierarchical clustering is based on a
distance function that quantiﬁes that extent of shared clones across site-isotype combinations, and is shown on the top of the heatmap as a dendrogram.
b–d Lineage trees showing dispersed clones of predominantly single isotype comprised of IgA (diamonds), IgM (stars) and IgG (squares). Recombining
segments and junctional sequence of the most recent common ancestor (MRCA) of the clones are: b IGHV3-30, IGHJ4*02 TGTGCGAAAAAGGTTG
SGGGAGGTCCGAAAACAGAAG GGGTTGACTACTGG. c IGHV3-23, IGHJ4*02 TGTGCGAAAGGTAGCGGGTCRKCTCGCCCGTACTACTTTGACTACT
GG. d IGHV5-51*01, IGHJ3*02 TGTGCGAGACTTGACGGTAGCAGCAGTACTGATTGTCTTGATATYTGG
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Human MZ B cells diversify their IGHV genes in GALT. While
GALT CD27+IgM+IgD+ and CD27+IgM+IgD− clones both
contained members that could be found within the GC, their
association with IgA expressing cells was clearly different. No
GALT IgA+ members were identiﬁed among the 3957 GALT
CD27+IgM+IgD+ containing clones (range 59–2516 clones)
identiﬁed across all three sites in four donors. This was sig-
niﬁcantly different from GALT CD27+IgM+IgD− containing
clones where 105 of 7969 (range 19–48 of 1089–2660 clones)
included GALT CD27+IgA+ members (combined P value < 10−8
Donor 1
A
B
CF
Inferred
Germline
CD27+IgD+
CD27+IgD–
Donor 2 Donor 3 Donor 4
Donor 1 Donor 2 Donor 3 Donor 4
Gut
CD27+ IgD– IgA
Blood
CD27+ IgD+ IgM
Blood
CD27+ IgD– IgM
Blood I CD27+ IgD+ I IgM
5
89
9
34
9
11
08
59
31
3
45
50
2
29
6
11
32
14
95
85
3
24
52
17
9
30
0
11
22
6
78
9
65
6
15
76
10
4285
2
15
54 75
25
31
26
79
92
2
4
89
15
7
91
52
2
12
53
17
97
65
2
10
0
59
1
37
3
5
38
26
51
07
40
73
13
3
13
05
26
37
46
0
35
9
13
2
22
4
45
0
55
1
16
79
19
42
68
3
54
8
77
1
40
4
60
6
15
14
40
50
22
96
22
86
55
2
79
9
17
95
75
31
60
4
38
4
60
9
14
90
16
99
32
8
12
33
13
29
31
0
14
7
80
19
7
15
45
25
16
(0.56%) (2.89%) (1.69%) (2.22%) (0.6%)
(0.68%) (1.83%)
(0.32%) (2.58%)
(3.16%) (1.05%) (0.68%)
(1.29%) (0.51%) (1.29%) (5.48%) (0.19%)
(0.36%)
(6.89%)
(0.45%)
(0.76%) (17.42%)
(2.79%)
(0.22%)
(0.07%)
(0.04%)
(0.61%) (0.09%) (1.16%) (0.55%)
(1.73%)
(0.16%) (0.13%)
(0.13%)
(0.18%) (0.05%)
(0.07%)
(0.29%)(3.09%)
(4.98%)
(2.17%)
(1.46%)
(3.62%)(16.16%)
(0.45%) (4.46%)
(0.76%)
(1.79%)
(0.73%)
(0.45%)
(0.5%)
(1.52%)
(1.56%)
(0.15%) (2.08%) (0.65%) (0.28%) (0.89%)
(0.67%) (1.02%)
(0.89%) (10.89%) (1.33%)
(1.33%)
(2.67%)
(1.27%)
(2.67%) (15.73%)
(0.43%)
(25.33%)
(38.67%)
(1.38%) (0.03%)
(0.05%) (1.34%)
(1%)
(0.34%) (0.45%)(1.23%)
(10.53%) (10.53%)
(5.1%)
(0.64%)(12.74%)
(1.12%) (25%)
(18.68%) (2.2%)
(0.4%)
(0.96%) (13.79%) (2.49%)
(1.27%)
(2.55%) (19.78%) (0.77%)
(1%) (1%)
(14.29%) (13.41%)(6.3%) (3.15%)
(0.65%) (0.56%)(5.81%)
(1.11%) (1.39%)
(1.34%)(4.57%) (1.62%)
(0.07%)
(1.22%)
(0.16%)
(2%)
(3.4%)
(1.52%)
(1.25%)
(5.44%)
(0.18%)
(2.23%)
(2.54%) (0.13%)
(0.5%)
(0.11%)
(0.49%)
(0.26%)
(0.17%)
(0.18%)
(0.06%)
(0.61%)
(0.1%)
(0.91%)
(0.71%)
(2.04%)
(1.25%) (1.25%) (2.5%)
(0.51%) (4.57%) (9.64%) (2.04%) (3.75%)
(1.09%) (0.89%) (0.08%) (5.44%)
(9.8%)
(1.69%) (7.43%)
(2.39%) (1%)
(1.69%)
(2.22%)
(48.39%)
(2.11%)
(5.44%) (0.12%)
(0.86%)
(1.17%) (0.27%) (2.33%) (0.51%) (0.07%)
(0.44%)(0.91%)
(4.44%) (2.22%) (3.23%)
32 1
1
1 3
5 22
12 5
1
15
19
19
3
10 4 7 4 1
76
2 1 1
2 12
29 1
17 42 14 1
1 8 1
1 1
1
2
2
2 14
4
2
19
29
14 14
35
47
20 1
1 1
1
5
1
2 8 8
17 2
2
4 18 5
1 1
13 70
2
28 4 1 4
9
3
20 4 4
4
4 603 3
3 3 3 7
2
2
731
35
32
5
5
5
79
72 13
29
5
2
17
29 6 11
19 3 3
1
1 1
1 1
1
1
1
1
2 7 3
7
14
1
1 1
11 1 248
65
19
1 2
2
23
58 10
10
13
1 110
1
3
9
3
11
11
1
1 1 2
1
5 2
4
3
1
8
19
14
Gut I GC I IgM
Gut I GC I IgG
Gut I GC I IgA
Blood I CD27+ IgD– I IgM
Blood I CD27+ IgD– I IgA
Gut I CD27+ IgD+ I IgM
Gut I CD27+ IgD– I IgM
Gut I CD27+ IgD– I IgG
Gut I CD27+ IgD– I IgA
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
A
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
G
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
M
G
ut
 I 
CD
27
+ 
Ig
D+
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
A
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D+
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
A
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D+
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
A
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D+
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
A
Bl
oo
d 
I C
D2
7+
 Ig
D–
 I 
Ig
M
Bl
oo
d 
I C
D2
7+
 Ig
D+
 I 
Ig
M
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
A
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
G
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
M
G
ut
 I 
CD
27
+ 
Ig
D+
 I 
Ig
M
G
ut
 I 
G
C 
I I
gA
G
ut
 I 
G
C 
I I
gG
G
ut
 I 
G
C 
I I
gM
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
A
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
G
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
M
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
A
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
G
G
ut
 I 
CD
27
+ 
Ig
D–
 I 
Ig
M
G
ut
 I 
CD
27
+ 
Ig
D+
 I 
Ig
M
G
ut
 I 
G
C 
I I
gA
G
ut
 I 
G
C 
I I
gG
G
ut
 I 
G
C 
I I
gM
G
ut
 I 
CD
27
+ 
Ig
D+
 I 
Ig
M
G
ut
 I 
G
C 
I I
gA
G
ut
 I 
G
C 
I I
gG
G
ut
 I 
G
C 
I I
gM
G
ut
 I 
G
C 
I I
gA
G
ut
 I 
G
C 
I I
gG
G
ut
 I 
G
C 
I I
gM
Gut
GC IgG
Gut
CD27+ IgD– IgG
Gut
GC IgA
Gut
GC IgM
Gut
CD27+ IgD+ IgM
Gut
CD27+ IgD– IgM
Blood
CD27+ IgD– IgA
a
b
c
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06089-1 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:3857 | DOI: 10.1038/s41467-018-06089-1 | www.nature.com/naturecommunications 9
by Fisher’s method) (Fig. 8). Of the 3957 clones that included
CD27+IgM+IgD+ cells in GALT, 26 (0.7%) had clone members
in GC, but none of these contained IgA+ clone members. Of 7969
clones including CD27+IgM+IgD− cells in GALT, 59 (0.7%) had
clone members in GC, of which 16 had GC IgA+ clone members.
The frequency of IgA switched variants amongst the GC cells was
signiﬁcantly higher if clones contained CD27+IgM+IgD−
cells compared to clones containing CD27+IgM+IgD+ cells
(combined χ2 P value= 0.0065 by Fisher’s method). While
CD27+IgM+IgD− cells were observed to be clonally related to
both CD27+IgM+IgD+ cells and IgA variants, these relationships
occurred in distinct sets of CD27+IgM+IgD− clones.
Discussion
Here we provide a multidimensional view of human B cells in
lymphoid tissues that separates classical memory B cells from MZ
B cells. For the ﬁrst time, we observed a phenotypic progression
from the naïve B cell pool via CD27−CD45RB+ MZ precursor
cells to MZ B cells. This was evident in all tissues though we
found no evidence for any site studied being speciﬁcally asso-
ciated with progression through these stages. Although positioned
closely to transitional cells in the viSNE plots, the MZ precursor
cells did not form a phenotypic continuum with the transitional
pool in the SPADE analysis, suggesting that they are not strictly
T3 transitional cells that are formed as cells progress from T1 and
T2 stages to become naïve cells. Rather, they appear to be later
precursors in developmental terms that have acquired some
properties of naïve B cells8,9,31. The developmental sequence is
consistent with the observation of a relatively high abundance of
CD27−CD45RB+ in children, in emerging B cells following
hematopoietic stem cell transplantation and with differentiation
of MZ B cells from splenic CD27−CD45RB+ precursors by
NOTCH2 ligation8,9. It cannot be determined at this point
whether NOTCH2 ligation is restricted to the spleen or can also
occur in GALT, and if other signals in addition to NOTCH2
ligation can mediate the selection into the MZ lineage.
By imaging mass cytometry we observed that class switched
memory B cells and MZ B cells are both present in GALT but that
they have different microanatomic distributions. Whilst class
switched memory cells were distributed around the periphery of
the entire lymphoid tissue, MZ B cells had a more conﬁned
distribution between the GC and the follicle-associated epithe-
lium. The area containing MZ B cells had class switched memory
cells on all boundaries except at the interface between the MZ and
the GC. The distribution of memory cells around the periphery of
the tissue would place them on the antigenic front line in close
proximity to potential pathogens. The signiﬁcance of the dis-
tribution of MZ cells internal to the memory subset but adjacent
to the GC is unclear, though resemblance between cells in this
area and GC cells has been noted previously25. The associated
expression of CD80/CD86 by B cells between the GC and follicle-
associated epithelium in this study was conﬁrmed here by mass
cytometry while not by imaging mass cytometry.
As described before, we conﬁrm that CD45RB was expressed
by class switched CD27+ and CD27− subsets of memory
cells17. Hence, it is interesting to note that a population of
CD27−IgM+IgD− cells were identiﬁed here that were phenoty-
pically similar to CD27− and CD27+ subsets of IgA memory cells
and that included cells that were CD45RB+. It is possible that this
represents a population of CD27−IgM+ memory cells with
highest relative abundance in the gut that is currently unappre-
ciated and that require further attention.
Based on IGHV gene analysis, we observed that IgM-only cells
could be clonally related to both MZ and memory B cells but not
within the same clone in GALT. Moreover, by imaging mass
cytometry we observed that IgM-only cells shared both MZ and
class switched memory microanatomical biases. Taken together,
this suggests that IgM-only cells in GALT can belong to either
the MZ or memory developmental axis. This is in contrast to
Bagnara et al. who proposed that IgM memory B cells can be
either CD27+IgM+IgD− or CD27+ IgM+IgD+ in blood and
spleen5. We show that in terms of derivation, microanatomy and
clonal segregation, CD27+IgM+IgD+ are not synonymous with
classical memory cells but that IgM-only cells can belong to either
compartment and cannot currently be assigned to either com-
partment by phenotype alone.
The IGHV gene analysis also demonstrated that GALT MZ
and class switched memory B cells were rarely clonally related
which is consistent with our observations made by mass cyto-
metry and imaging mass cytometry, highlighting that the two
populations represent separate developmental pathways. We
cannot exclude the possibility that the total lack of IgA variants
within CD27+IgM+IgD+ clones was due to the limited number
of cells harvested from each site from each individual. However,
the observation that similar frequencies of CD27+IgM+IgD+ and
CD27+IgM+IgD− clones were associated with the GC argues for
our ability to detect clonal relationships between these small,
accurately sampled populations. Thus, even though we cannot
exclude switching, our data demonstrate that if such switching
occur, it is less prevalent among GALT MZ lineage cells than B
cells differentiating along a conventional memory developmental
axis.
Circulating and splenic CD27+IgM+IgD+ B cells have muta-
tions in their IGHV genes implying previous GC exposure5,32,33.
This contrasts with mouse MZ B cells that differentiate from T2
cells in spleen and do not have this feature34. Based on the pre-
sence of CD27+IgM+IgD+ cells with mutations in their IGHV
genes in CD40L deﬁcient patients, it has been suggested that
mutations in IGHV genes in CD27+IgM+IgD+ cells are GC and
potentially even AID independent1,35. Our study does not exclude
these possibilities. However, we show that in healthy individuals,
mutations can be introduced into MZ B cells in GALT GC. We
detected CD27+IgM+IgD+ B cells that were clonally related to
GC B cells, and we were able to detect AID in isolated GC cells
from GALT but not CD27+IgM+IgD+ B cells. GC are present in
GALT from the ﬁrst days after birth and the small abortive GC
that can occur in CD40L deﬁcient patients could potentially
support some mutation of IGV genes in GALT36,37. Overall,
our results support a model where mutations in IGHV genes of
CD27+IgM+IgD+ B cells are acquired in the GCs of GALT. In
this case, mutations in BCL6 in CD27+IgM+IgD+ MZ cells
observed by others would also be acquired in GC of GALT6, and
Fig. 6 Clonal dissemination of B cell subsets. Analysis of B cells from three different sites from each of four tissue donors (a) Circos plots showing the
clonal relationships between B cells in the gut and CD27+IgM+ subsets and CD27+IgA+ cells in blood for Donors 1–4. Sequences clonally related across
tissue-isotype-subset are connected by lines, with sequences spanning gut CD27+IgM+IgD+ and gut CD27+IgM+IgD− subsets coloured green and
blue, respectively. All other connections are coloured light grey. b Numbers and percentages illustrating distribution of clone members (top triangles)
and unique sequences (bottom triangles) from B cell subsets across different sites sampled. c Lineage tree depicting a shared lineage of blood and GALT
CD27+IgM+IgD+ cells. Recombining segments of the clone were IGHV5-51*01, IGHJ4*02, junctional sequence TGTGCGAGACACGAGATGG
AAGTGGCTGGTGCT TACCTTGGCTTCTGG
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for the reasons stated above mutated BCL6 in CD27+IgM+IgD+
B cells does not warrant their classiﬁcation as classical memory B
cells.
Consistent with other work, we show that class switched
memory B cells are the most abundant B cells in human GALT
and that most express IgA15. By IGHV gene analysis we show
that clones of memory B cells disseminate through the gut and
blood, spanning distant sites over one metre of intestine, con-
sistent with distribution of mucosal memory B cells in mice.
These clones continue to expand and evolve in the GC but we
observe no overarching tendency for local accumulations other
than in GC. This distribution of memory cells occurs despite the
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Fig. 7 CD27+IgM+IgD+ cells diversify their receptors in gut GC. a, b Lineage trees including clone members isolated from GC of GALT, CD27+IgM+IgD+
cells from GALT and in (b) also CD27+IgM+IgD+ cells from blood. CD27+IgM+IgD+ cells before and after the GC phase were identiﬁed, indicating that
the response is current and dynamic and generating cells enter and exit the GC response with the same (CD27+IgM+IgD+) phenotype. CD27+IgM+IgD−
clone members can also be identiﬁed. Recombining segments and junctional sequences of the MRCA of the clones are: a, IGHV3-33, IGHJ4*02
TGTGCGAGAGGGATCAA CTACGGTGACGCCGACGGCTTT GACAACTGG. b, IGHV5–10*01, IGHJ4*02 TGTGCGAGACATTTTGGGCACTACTTTG
ACTACTGG
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vastly different antigenic environments from which cells are
isolated and the different bacterial species the lymphoid tissue
will be exposed to in the ileum and the colon. This suggests that
classical gut memory cells arising from exposure to infection or
vaccine could disseminate to provide wide coverage and rapid
immune protection over time, consistent with intestinal memory
B cell persistence in mice38,39.
It is interesting to note that B cells that would be classiﬁed as
the same subset according to expression of conventional groups
of markers can differ in their expression of other functionally
relevant antigens depending on location. Splenic B cells tended to
express higher levels of CD21 and CD180, both associated with
innate B cell responses, compared to equivalent subsets in the
tonsil or GALT. This implies that such antigens can be locally
enhanced as B cells enter tissues or that separate migratory
subsets of cells exist that otherwise appear equivalent. This will be
an important area for future investigation.
In summary, by spatiotemporal analysis of B cells in tissues we
visualise phenotypic progression from CD27−CD45RB+ pre-
cursors to marginal zone B cells in humans separate from
memory cells, and that marginal zone and memory B cells occupy
different microenvironments in GALT. Human MZ B cell
development involves a stage of clonal expansion and repertoire
diversiﬁcation in the GC of GALT, thus endowing them with
signatures of GC experience that were previously unexplained.
Methods
Tissue samples. All tissues used in this study were collected with ethical approval
from UK Research Ethics Committees administered through the Integrated
Research Application System. All samples were collected with informed consent.
Gut biopsies (PP, A, CF) and paired blood samples were from 45 healthy patients
undergoing investigative colonoscopy who had no evidence of inﬂammation or
other pathology. Details of age of these tissue donors is in Supplementary Fig. 12b.
In addition, non-inﬂamed tonsils from ﬁve adult patients were collected from
surgical theatres. Normal spleen samples were from six cadaver organ donors. The
three snap frozen samples of normal appendix used were from two patients with
cancer who had undergone surgical right hemicolectomy (appendix 1 and 3) and
one cadaver donor (appendix 2). Surgical samples of spleen, tonsil and appendix
were all anonymous.
Mononuclear cells from gut biopsies and paired peripheral blood and from
tonsil and spleen were isolated as previously described40. Tonsil and spleen cell
suspensions were cryopreserved before use.
Mass cytometry. Antibodies to be used for mass cytometry (Supplementary
Table 1) were either purchased ready tagged from Fluidigm or else purchased
protein free from the suppliers as indicated in Supplementary Table 1 and con-
jugated in house using MaxPar labelling kits from Fluidigm according to the
manufacturer’s instructions. For viability staining, 2 × 106 cells were washed in PBS
containing 0.5% BSA with 2 mM EDTA (cell-staining medium: C-SM) and incu-
bated for 20 min in 1 ml rhodium intercalator (Fluidigm) diluted 1:500 in PBS.
Cells were washed twice in C-SM, prior to resuspending the cell pellet in 10 mcl
Kiovig Fc block (5 mg/ml; Baxter) for 10 min at room temperature followed by
staining with the panel of metal-conjugated Abs using previously titrated con-
centrations, in a total volume of 100 μl on ice for 30 min. After two further washes
in C-SM cells were ﬁxed in 2% PFA in PBS at 4 °C overnight. Cells were cen-
trifuged and counterstained with 500 μl perm buffer (0.3% saponin (Sigma) in C-
SM) and 100 μl intercalatin Ir (Fluidigm) for 30 min at room temperature. Cells
were then washed twice with 1 ml PBS and twice with 1 ml Milli-Q water and
resuspended in Milli-Q water with EQ beads (DVS Sciences) and the cell con-
centration adjusted to 0.5 × 106 cells/ml. Data were acquired immediately using a
CyTOF mass cytometer as described previously and ﬁles exported in ﬂow cyto-
metry ﬁle (FCS) format for analysis of data to Cytobank (https://mrc.cytobank.org).
The effect of mild collagenase digestion on binding of antibodies by this method
revealed that TACI, CD62L and CCR6 were reduced by digestion (Supplementary
Fig. 19). Since cryopreservation was used for tonsil and spleen but not GALT or
PBMC, the effect of cryopreservation on the method and of potential relative loss
of populations such as plasmablasts was tested and found to have no apparent
effect (Supplementary Fig. 20).
Analysis of mass cytometry. FCS ﬁles were normalised using Nolan Lab Nor-
malizer software (v0.3, available online at https://github.com/nolanlab/bead-
normalization/releases). Pre- and post- normalisation plots are shown in Supple-
mentary Fig. 1. FCs ﬁles were concatenated using The Cytobank FCS ﬁle con-
catenation tool (available online at https://support.cytobank.org/hc/en-us/articles/
206336147-FCS-ﬁle-concatenation-tool). Concatenated normalised ﬁles were then
uploaded onto the Cytobank (https://mrc.cytobank.org/) and gated as shown
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(Supplementary Fig. 1). A total of 144,367 live single CD19+ cells from GALT,
spleen and tonsil (total 433,101) were then included in the viSNE analysis using
CD10, CD24, CD27, CD38, IgA, IgD, IgM, IgG and HLADR. Manually gating the
viSNE plots was difﬁcult due to the gradient of expression of many markers. In
addition, SPADE as a clustering tool alone was found to be poorly reproducible
(Supplementary Fig. 21). Methods such as PhenoGraph41 (for example) generated
interesting B cell subset data but this was difﬁcult to tie to existing literature and
other datasets and were therefore not pursued for this study (Supplementary
Fig. 22). SPADE was therefore run on viSNE using tSNE 1 and tSNE 2 as clustering
parameters allowing identiﬁcation of B cell subsets by the arrangement of phe-
notypically similar nodes into SPADE bubbles.
Multidimensional scaling was used to visualise the phenotypic similarities and
differences in the SPADE bubbles exported as .fcs ﬁles between biological samples
and anatomical sites prior to concatenation16. Each point represents a sample, and
the distances between the points are proportional to the Euclidean distance
between the samples. Kruskal stress shows how much information was lost during
the dimension reduction steps.
To test whether the CD45RB+ cells constitute a population with a distinctive
phenotypic proﬁle within the naive B cell population, a bootstrapping procedure
(random sampling with replacement) was implemented. A number of cells equal to
the number of cells observed in the CD45RB+ bubble for each tissue was randomly
sampled from the naïve B cell SPADE bubble for 10,000 times. Each time, the
median expression for each marker across all sampled cells was measured to derive
the expected distribution of expression markers. This distribution was compared
with the median expression values in the observed CD45RB+ population, and z-
scores were used to determine if there is a signiﬁcant difference between the two
populations18–20.
Imaging mass cytometry. Frozen sections of 4 μm thickness were cut onto glass
slides and stored at −80 °C. Immediately before use they were raised slowly to 4 °C
and ﬁxed for 30 min in 4% PFA in PBS at 4 °C. Sections were washed twice in 37 °C
0.1% Tween-20 in PBS for 8 min followed by incubation in blocking solution (0.1%
Tween-20, 1/20 FcR block [Trustain, Biolegend], 5 mg/ml human IgG [5% KIO-
VIG, Baxalta UK Ltd.] and 5% BSA in Superblock [Thermo Fisher Scientiﬁc]) for 1
h at room temperature. Sections were then stained overnight at 4 °C in pre-titrated
primary antibodies diluted in blocking solution. Sections were then washed twice
with PBS 0.1% Tween-20 for 8 min prior to counterstaining with 0.5 µM
Intercalator-Ir (Fluidigm) diluted in PBS, for 30 min at room temperature. Fol-
lowing washes in PBS and water, slides were air dried prior to ablation. Data were
acquired on a Hyperion imaging system coupled to a Helios Mass Cytometer
(Fludigm), at a laser frequency of 200 Hz and laser power of 6 dB.
When the individual ablation regions were smaller than the region of interest,
images were stitched together in MATLAB by shifting the x and y co-ordinates of
sequential ablations to create a full region of interest. Initial analysis used MCD
viewer to identify areas for further investigation by creating a number of overlaid
images depicting a set of relevant markers. The inbuilt thresholding tools were used
to clean up pixels with very low intensity values resulting from, for example, cross
channel and system noise. Files were exported in TIFF format. These were then used
to create Fig. 4a, b; Supplementary Fig. 7 and 11 in Fiji software (https://ﬁji.sc/).
The protocol for creation of Fig. 4c–l and Supplementary Fig. 8–10 is illustrated
in Supplementary Fig. 5. Images created by imaging mass cytometry were stitched
together when required in MATLAB and imported to MCD viewer. Data were
exported as a stacked TIFF ﬁle from MCD viewer and converted to FCS ﬁles in
MATLAB with each event representing a pixel and not a cell as in standard
cytometry. FCS ﬁles were uploaded onto the Cytobank server. In Cytobank the x
and y parameters were displayed on a linear scale and gates of the regions of
interest were created. viSNE analysis was run on the pixels in these gates with all
panel markers. SPADE was run on viSNE to identify nodes containing CD19+
CD20+ pixels. Nodes were grouped in SPADE bubbles and exported for further
analysis. A sequential viSNE analysis was run using B cell markers CD10, CD19,
CD20, CD24, CD27 CD38, CD45RB, IgM and IgD from the panel. SPADE was run
on the second viSNE to group nodes into SPADE bubbles that corresponded to B
cell subsets. The SPADE bubble named ‘other’ contained nodes that could not be
placed conﬁdently within SPADE bubbles representing known B cells subsets and
were therefore excluded. Events within SPADE bubbles representing B cell subsets
were exported from Cytobank and converted in MATLAB to a MCD Viewer
readable text format. The B cell subset pixels were then mapped back to the region
of interest and pseudocoloured in MCD viewer.
Flow cytometry and cell sorting. All ﬂow cytometry used appropriate isotype
controls. Gating and compensation were aided by the performing ﬂuorescence
minus one controls. Cells isolated from biopsies or blood were stained with blue-
ﬂuorescent reactive dye (Life Technologies), CD19-BV785, CD27-APC (BD Bios-
ciences) or PE or BV421, CD10-BV605 or APC, CD38-PerCp-ef710 (eBioscience),
CD24-PE/Cy7 or BV605, IgD-APC/Cy7, IgM-V450 (BD Biosciences), IgG-PE/Cy7
and IgA-FITC (Miltenyi Biotec), in 2% FCS staining buffer with 1 mM EDTA for
15 min at 4 °C before analysis on the BD LSRFortessa (BD Biosciences). For high-
throughput sequencing analysis, cells were stained with LIVE/DEAD Fixable Aqua
(Life Technologies) or DAPI, CD19-BV785, CD27-FITC or APC, IgD-APC/Cy7,
CD38-PerCp-ef710 (eBiosciences), CD10-BV605 in 2% FCS staining buffer with 1
mM EDTA for 15 min at 4 °C before sorted on the BD FACSAria (BD Biosciences).
Four subsets from PBMC and three subsets from paired biopsy mononuclear cells
from Donors 1 to 4. The numbers of cells used to generate sequences for each
sample from Donors 1 to 4 are shown in Supplementary Fig. 14d.
High throughput sequencing of immunoglobulin genes. RNA from sorted cells
was isolated using an RNeasy Mini Kit (Qiagen) according to manufacturer’s
instructions. For cells from Donors 1 to 4, cDNA synthesis was repeated eight
times for each sample using SuperScript III First-Strand Synthesis Supermix
(Invitrogen) according to manufacturer’s instructions (Supplementary Fig. 14c).
The reaction was performed at 25 °C for 10 mins, 50 °C for 30 min, 85 °C for 5 min
and then chilled on ice before adding RNase and incubation at 37 °C for 20 min.
Immunoglobulin genes were ampliﬁed by nested PCR using isotype-speciﬁc pri-
mers as described previously: for VH1-6/7 leader (1st PCR; PCR1) and FW1-VH1-
6/7 (2nd PCR; PCR2)28,42 in conjunction with nested, constant region primers. In
brief, PCR1 was performed in 20 μl reaction mix containing 2 μl of cDNA, 10 μl of
Q5 High-Fidelity 2X Master Mix (NEB), IGHV1-6/7 forward primers (83.2 nM
each) and reverse primers (500 nM; either CHA″, CHG″ or CHM″ for IgA, IgG
and IgM respectively). The nested PCR2 was then performed in 50 μl reaction mix
containing 5 μl PCR1 products, 25 μl of Q5 High-Fidelity 2X Master Mix (NEB),
forward FW1-VH1-6/7 primers (83.2 nM each) and nested reverse primers (500
nM), both tailed with 10-nucleotide multiplex-identiﬁer (MID). Two rounds of
PCR were performed with the same programme: 98 °C for 30 s, followed by 20
cycles of 98 °C (5 s), 60 °C (10 s), 72 °C (20 s) and ﬁnal extension at 72 °C for 2 min.
Primer sequences28 are in Supplementary Table 3.
After ampliﬁcation, PCR primers were removed from the pooled (×8) products
of each sample by electrophoresis and QIAquick Gel Puriﬁcation Kit (Qiagen).
The concentration of each sample was measured using Qubit ﬂuorometer
(Invitrogen). Samples to be pooled for sequencing were mixed in equal quantities,
and further puriﬁed and concentrated using Silica Bead DNA Gel Extraction Kits
(Thermo Fisher Scientiﬁc). Samples (including all isotypes from all sorted cell
subsets) from the same gut biopsy site (e.g. PP) of four individual donors
were pooled into one sequencing lane. Samples (including all isotypes from sorted
CD19+CD27+ and plasmablast cell subsets) from PBMC of four individual donors
were pooled as one for sequencing on one sequencing lane. Samples from
CD19+CD27−sorted PBMC were separately pooled for another sequencing lane.
Pyrosequencing was performed on the Roche 454 GS FLX+ System by LGC
Genomics (Germany). The procedure of sample preparation is illustrated in
Supplementary Fig. 14c.
Sequence analysis: processing raw reads. Bioinformatics analysis was carried
out using the Immcantation framework (http://immcantation.readthedocs.io). Raw
high-throughput sequencing reads were processed and ﬁltered for quality using
pRESTO43. Reads of length less than 250 and mean Phred quality score less than 20
were removed. Next, MIDs on the 5′ and 3′ were identiﬁed and annotated. Reads
without exact sequence matches to the MIDs were removed. The forward (V
region) and reverse (constant region) primers were matched with maximum error
rate of up to 0.2. The forward primer regions were masked with Ns while the
reverse primer regions were trimmed from the reads. Reads with identical
nucleotide sequence, MIDs, forward and reverse primers were collapsed into a
single sequence.
V(D)J germline assignment and further quality control. Following processing of
raw sequencing data using pRESTO Version 0.5.0-2015.07.29, germline V(D)J
segments were identiﬁed using IMGT/HighV-QUEST Version 3.3.244. Further
quality control and advanced sequence analysis was carried out using Change-O45
and R (R Core Team, 2015). Sequences identiﬁed as non-functional by IMGT/
HighV-QUEST and those with non-matching MIDs (suggesting they were chi-
meras) were removed. Finally, sequences with more than ﬁve mutations in a sliding
window of 10 base pairs that were likely to be chimeric sequence artefacts were also
removed (Supplementary Fig. 23a).
Clonal grouping and lineage tree construction. Each set of sequences was par-
titioned into clonal groups using a two-step approach. Initially sequences were
grouped based on common germline IGHV and IGHJ gene assignment and
identical junction length. Within these larger groups, sequences differing from one
another by a distance of less than 0.2 were deﬁned as clones. Distance between
sequences was measured as the number of nucleotide differences in the CDR3, with
each difference weighted by the human S5F model of somatic hypermutation
targeting and substitution46 as previously described47. This distance was normal-
ised by dividing by the CDR3 length. The threshold of 0.2 was chosen by manual
inspection of the distance-to-nearest plots generated for each individual (Supple-
mentary Fig. 23b). Lineages were constructed for each clonal group containing at
least two sequences as described47.
For formulation of heatmaps, the distribution of clones was calculated by
dividing the number of sequences in each clone by the total number of sequences at
the site. Hierarchical clustering was performed on the manhattan distance between
distributions of clones using the R function hclust with Ward.D agglomeration
method. The circos plots were created using the circlize package 0.3.10 in R48.
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Quantitative RT-PCR. Quantitative RT-PCR was as described previously TaqMan
qRT-PCR assays (Applied Biosystems) consisting of ampliﬁcation primers and
ﬂuorescently labelled MGB-probes were used to quantify AID expression49.
qRTPCR was performed in triplicate for each sample with each gene multiplexed
with an18s endogenous control (taqman assay labelled with different dye). Samples
were run on a viia7 qPCR machine (Applied Biosystems) and subjected to ΔCT
analysis relative to 18S expression.
Code availability. All code used in the manuscript is available on request.
Data availability
NGS data are available from NCBI under accession code: SRP161123; BioProject ID:
PRJNA478215. Other data are available on request.
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